INmune Bio and QCi Apply Quantum Optimization to XPro Research
Insider Brief PRESS RELEASE — INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential…
Mohib Ur Rehman
Publisher The Quantum Insider
Oct 14, 2026 at 3:38 PM UTC · Updated il y a 10 heures · 1 min de lecture
Insider Brief PRESS RELEASE — INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio’s investigational treatment for Alzheimer’s disease and other disease conditions. The collaboration brings together INmune Bio’s data from […]
Sourced by
Originally reported by The Quantum Insider
NewsLayer coverage based on externally reported material.
The Daily Brief
The onchain economy, before your day starts.
Curated markets, onchain insights, and key headlines — delivered every weekday morning.
Weekdays · Free · ~5 minute read
0
Applause
Was this article helpful?
Article Intelligence
Sponsored
Ad
NewsLayer Premium
Unlock deeper intelligence.
Ad-free reading, exclusive research, and real-time onchain insights.
Go Premium
